Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Bibliographic Details
Main Authors:	Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
by: Clark, W, et al.
Published: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
by: W. Clark, et al.
Published: (2003-01-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
by: Chen, Y, et al.
Published: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Y-F Chen, et al.
Published: (2006-11-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
by: Jobanputra, P, et al.
Published: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
by: Jobanputra, P, et al.
Published: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
by: P. Jobanputra, et al.
Published: (2002-01-01)

Infliximab in Crohn's disease
by: L. Rodrigo Sáez

Azathioprine and Infliximab: Monotherapy or Combination Therapy in the Treatment of Crohn's Disease
by: Bryan L. Love, et al.
Published: (2011-01-01)

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease
by: J Dretzke, et al.
Published: (2011-02-01)

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015-06-01)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept.
by: Cummins, C, et al.
Published: (2002)

Tratamento da doença de Crohn com infliximabe: primeira opção? Treatment of Crohn's disease with infliximab: first choice?
by: Anna Paula Rocha Malheiros, et al.
Published: (2009-06-01)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
by: Aibar Aginbay, et al.
Published: (2022-11-01)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease
by: Saeed Razmeh, et al.
Published: (2021-03-01)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
by: Burls, A, et al.
Published: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
by: A. Burls, et al.
Published: (2002-01-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
by: Diana Carvalho, et al.
Published: (2017-09-01)

Metastatic Crohn’s disease despite infliximab therapy
by: Sara Campos, et al.
Published: (2017-01-01)

Infliximab-induced psoriasis in a patient with crohn′s disease
by: Iqbal Bukhari, et al.
Published: (2015-01-01)

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
by: Hyder, SA, et al.
Published: (2006)

Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
by: Carlos Henrique Marques dos Santos
Published: (2014-07-01)

Successful Treatment of Postoperative Fistula with Infliximab in a Patient with Crohn's Disease
by: Seong Yeon Jeong, et al.
Published: (2014-01-01)

Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
by: Carlos Taxonera, et al.

Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity
by: Song Christine H, et al.
Published: (2012-11-01)

Infliximab therapy in pediatric Crohn&rsquo;s disease: a review
by: Kalyan Ray Parashette, et al.
Published: (2010-06-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
by: George Alex, et al.
Published: (2013-10-01)

Infliximab for the treatment of ulcerative colitis
by: C Hyde, et al.
Published: (2009-10-01)

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
by: Jong Lyul Lee
Published: (2019-10-01)

A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab
by: Xuan Shi, et al.
Published: (2023-08-01)

The use of infliximab in South-east Asian children with severe Crohn's disease
by: Lee, W.S.
Published: (2004)

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
by: Cassinotti, A, et al.
Published: (2009)

Infliximab for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2002)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
by: So Yoon Choi, et al.
Published: (2023-06-01)